CrushSCI.com
129Average days
125.5Median days
38Fastest days
231Longest days
3392025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

121 days

Thiochromen‐4‐One Derivatives as Potent Narrow‐Spectrum Antibiotics Against Moraxella

Authors
Barbara Hufnagel; Philipp Schmid; Micha Becker; Johannes Lehle; Felix Anderl; Thomas BöttcherShow moreShow less
Affiliations
1. Faculty of Chemistry, Institute of Biological Chemistry Centre for Microbiology and Environmental Systems Science (CeMESS) University of Vienna Vienna Austria; 2. Vienna Doctoral School in Chemistry (DoSChem) University of Vienna Vienna Austria; 3. Vienna Doctoral School of Pharmaceutical Nutritional and Sport Sciences (VDS PhaNuSpo) University of Vienna Vienna AustriaShow moreShow less
Source PDF DOI Publisher page
133 days

Multidrug Machine Learning Models for Predicting Human Immunodeficiency Virus‐1 Reverse Transcriptase Inhibitor Resistance

Authors
Sumeyye Yilmaz; Huseyin Tunc; Murat Sari; Serdar DurdağıShow moreShow less
Affiliations
1. Department of Mathematical Engineering Faculty of Science and Letters Istanbul Technical University İstanbul Türkiye; 2. Department of Biostatistics and Medical Informatics School of Medicine Bahçeşehir University İstanbul Türkiye; 3. Molecular Therapy Lab Department of Pharmaceutical Chemistry, School of Pharmacy Bahçeşehir University İstanbul Türkiye; 4. Lab for Innovative Drugs (LabIND) Computational Drug Design Center (HİTMER), Bahçeşehir University İstanbul Türkiye; 5. Systems Biology Lab Biruni University Scientific Research Center Biruni University İstanbul TürkiyeShow moreShow less
Source PDF DOI Publisher page
153 days

Artesunate Derivatives as Anticancer Agents: Hybrid Designs and Emerging Therapeutic Strategies

Authors
Milica Selaković; Ljiljana Koračak; Vladimir Ajdačić; Andrea M. Nikolić; Života Selaković; Ana Andrijević; Miguel Angel Merlos Rodrigo; Igor M. OpsenicaShow moreShow less
Affiliations
1. Innovative Centre of the Faculty of Chemistry in Belgrade, Ltd. Belgrade Serbia; 2. Department of Organic Chemistry Faculty of Chemistry University of Belgrade Belgrade Serbia; 3. Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech RepublicShow moreShow less
Source PDF DOI Publisher page
184 days

Novel Mn(II) Quinaldinate Complexes With Halogenated Imidazo[1,2‐a]pyridine and Memantine: Synthesis, Spectroscopic Studies, and Selective Pro‐Apoptotic and Pro‐Oxidative Activity in Cancer Cells

Authors
Tomasz Mazur; Magdalena Rydz; Barbara Machura; Kamila Środa‐Pomianek; Olga Wesołowska; Anna Palko‐Łabuz; Dariusz BieńkoShow moreShow less
Affiliations
1. Faculty of Chemistry Wroclaw University of Science and Technology Wrocław Poland; 2. Institute of Chemistry University of Silesia Katowice Poland; 3. Department of Biophysics and Neuroscience Wrocław Medical University Wrocław PolandShow moreShow less
Source PDF DOI Publisher page
222 days

Multiple Chemical Class‐Based Potent VEGFR2 Inhibitors as Anticancer Therapeutics: Structure–Activity Relationship and Chemicobiological Interactions Studies

Authors
Rinki Prasad Bhagat; Ajeya Samanta; Avik Maji; Abhik Paul; Sourav Mondal; Abdul Qadir; Nikki Gupta; Balaram Ghosh; Tapan Kumar MaityShow moreShow less
Affiliations
1. Synthetic and Natural Products Research Laboratory Department of Pharmaceutical Technology Jadavpur University Kolkata West Bengal India; 2. Department of Pharmaceutical Technology JIS University Kolkata West Bengal India; 3. Department of Pharmaceutical Chemistry Haldia Institute of Pharmacy Haldia West Bengal India; 4. Epigenetic Research Laboratory Department of Pharmacy Birla Institute of Technology and Science‐Pilani Hyderabad Telangana IndiaShow moreShow less
Source PDF DOI Publisher page
72 days

Metal–Organic Framework Synthesis Strategies for Efficient Encapsulation and Sustained Release of Bioactive Compounds

Authors
Danna P. Vázquez‐Poxtan; Lidia E. Chiñas‐Rojas; Enrique Flores‐Andrade; Jericó Bello‐Bello; Jesús A. Arenzano‐Altaif; Marisol Castillo‐Morales; Rafael Melo‐González; José María Rivera‐VillanuevaShow moreShow less
Affiliations
1. Facultad de Ciencias Químicas Universidad Veracruzana Orizaba Veracruz México; 2. SECHITI‐Colegio de Postgraduados‐Campus Córdoba Amatlán de los Reyes Veracruz México; 3. Facultad de Ingeniería Universidad Veracruzana (UV), Campus Ixtaczoquitlán Veracruz MéxicoShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does ChemMedChem take to review a manuscript?

As of 2026-11-17, CrushSCI has 30 complete review records for ChemMedChem. The fastest paper went from submission to acceptance in 38 days (Tearing Down Scientific Boundaries: Frontiers in Medicinal Chemistry 2026, received 2026-07-17, accepted 2026-08-24); the slowest took 231 days. The average is 129 days and the median is 125.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.